Brief: Centessa Pharmaceuticals Announces Pricing Of $100 Mln Public Offering Of American Depositary Shares
April 23 (Reuters) - Centessa Pharmaceuticals PLC
260y.F :
* CENTESSA PHARMACEUTICALS ANNOUNCES PRICING OF $100 MILLION
PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES
* CENTESSA PHARMACEUTICALS - PRICING OF UNDERWRITTEN PUBLIC
OFFERING OF 10.8 MILLION ADS, EACH REPRESENTING ONE ORDINARY
SHARE, AT A PRICE OF $9.25 PER ADS
Source text for Eikon: ID:nGNX5h3vzN
Further company coverage: 260y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Centessa Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Acquisition Of Centessa By Lilly Approved By The High Court Of Justice Of England And Wales
Street View: Lilly's $7.8 billion Centessa buyout validates sleep‑drug market
Press Digest: New York Times business news - April 1